These effects, together with a past report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two help the idea of targeting ACKR3 as a unique way to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant disorders. Conolidine promises being a innovative https://erics823wsx4.westexwiki.com/user